Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M; Adenoma Prevention with Celecoxib (APC) Study Investigators.

N Engl J Med. 2005 Mar 17;352(11):1071-80. Epub 2005 Feb 15.

PMID:
15713944
[PubMed - indexed for MEDLINE]
Free Article
2.

Celecoxib and cardiovascular risks.

Brophy JM.

Expert Opin Drug Saf. 2005 Nov;4(6):1005-15. Review.

PMID:
16255660
[PubMed - indexed for MEDLINE]
3.

New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.

Dubois RN.

Cancer Prev Res (Phila). 2009 Apr;2(4):285-7. doi: 10.1158/1940-6207.CAPR-09-0038. Epub 2009 Mar 31. Review. No abstract available.

PMID:
19336723
[PubMed - indexed for MEDLINE]
4.

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R.

J R Soc Med. 2006 Mar;99(3):132-40. Review.

PMID:
16508052
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.

Hochberg MC.

Clin Exp Rheumatol. 2001 Nov-Dec;19(6 Suppl 25):S15-22. Review.

PMID:
11695246
[PubMed - indexed for MEDLINE]
6.

Current perspective on the cardiovascular effects of coxibs.

Konstam MA, Weir MR.

Cleve Clin J Med. 2002;69 Suppl 1:SI47-52. Review.

PMID:
12086293
[PubMed - indexed for MEDLINE]
Free Article
7.

Chemoprevention in colorectal neoplasias: what is practical and feasible?

Ricciardiello L, Roda E, Bazzoli F.

Dig Dis. 2002;20(1):70-2. Review.

PMID:
12145422
[PubMed - indexed for MEDLINE]
8.

COX-2 inhibitors.

Becker RC.

Tex Heart Inst J. 2005;32(3):380-3. Review.

PMID:
16392224
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back.

Bertagnolli MM.

Lancet Oncol. 2007 May;8(5):439-43. Review.

PMID:
17466901
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk